Exicure, Inc. (XCUR)
XCUR moved a median of 0.00% 30 minutes after news, and 0.00% by the close. How XCUR actually reacts to news — the realized, point-in-time move the market made, measured across 173 labeled events over the last three years with zero look-ahead.
XCUR’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 47% | 129 |
| 30-min | 0.00% | 49% | 167 |
| 60-min | +0.30% | 51% | 170 |
| to close | 0.00% | 49% | 172 |
| Middle 50% of XCUR reactions | -3.10% to +2.29% |
|---|---|
| Median reaction (30-min) | 0.00% |
| Measured reactions | 173 |
Half of all Exicure, Inc. news events land between -3.10% and +2.29% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when XCUR moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to XCUR's baseline. Nothing else.
Recent XCUR events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Exicure Receives Nasdaq Extension to Regain Compliance with Stockholders’ Equity Requirement | Press release | GlobeNewswire | — | +2.31% | |
| Form 8-K EXICURE, INC. For: Sep 16 | SEC filing · Form 8-K | SEC EDGAR | — | +1.92% | |
| Form 10-Q EXICURE, INC. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | — | -0.79% | |
| Exicure to Settle GPCR Therapeutics Clinical Milestone Payment Through Equity Issuance | Press release | GlobeNewswire | +3.62% | +3.95% | |
| Exicure Announces Board and Committee Changes | Press release | GlobeNewswire | +16.91% | -2.35% | |
| Form 8-K EXICURE, INC. For: Jun 30 | SEC filing · Form 8-K | SEC EDGAR | -0.98% | +2.46% | |
| Exicure Announces Receipt of Nasdaq Notice Regarding Minimum Stockholders’ Equity Requirement | Press release | GlobeNewswire | — | +2.17% | |
| Exicure Announces Receipt of Nasdaq Delinquency Notice and Filing of Form 10-Q | Press release | GlobeNewswire | -0.60% | -6.61% | |
| Form 8-K EXICURE, INC. For: Jun 01 | SEC filing · Form 8-K | SEC EDGAR | — | +2.46% | |
| Form 10-Q EXICURE, INC. For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | — | +0.95% | |
| Form NT 10-Q EXICURE, INC. For: Mar 31 | SEC filing · Form NT | SEC EDGAR | +0.00% | +5.52% | |
| Exicure Announces Co-Development Agreement with Adbiotech for Burixafor (GPC-100) | Press release | GlobeNewswire | +2.49% | +0.83% | |
| Form 8-K EXICURE, INC. For: Apr 08 | SEC filing · Form 8-K | SEC EDGAR | — | +1.53% | |
| Form 8-K EXICURE, INC. For: Apr 02 | SEC filing · Form 8-K | SEC EDGAR | — | -8.22% | |
| Summary Notice of Pendency and Proposed Settlement of Stockholder Derivative Actions | Press release | GlobeNewswire | — | -8.22% | |
| Form 8-K EXICURE, INC. For: Mar 25 | SEC filing · Form 8-K | SEC EDGAR | +2.04% | +1.20% | |
| Exicure, Inc. Reports Full Year 2025 Financial Results | Press release | GlobeNewswire | — | +1.99% | |
| Form 10-K EXICURE, INC. For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | — | +1.99% | |
| Form 8-K EXICURE, INC. For: Mar 25 | SEC filing · Form 8-K | SEC EDGAR | — | +1.99% | |
| Form 8-K EXICURE, INC. For: Feb 11 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -3.43% | |
| Form 8-K EXICURE, INC. For: Feb 06 | SEC filing · Form 8-K | SEC EDGAR | — | -1.39% | |
| Exicure Announces Publication in Annals of Hematology Highlighting Rapid Stem Cell Mobilization with Burixafor in Patients with Multiple Myeloma and Lymphoma Undergoing Transplant | Press release | GlobeNewswire | +2.16% | +2.16% | |
| Form 8-K EXICURE, INC. For: Jan 16 | SEC filing · Form 8-K | SEC EDGAR | -0.10% | -3.60% | |
| Exicure to Present Data from Burixafor Phase 2 Trial at the 2026 Tandem Meetings | Press release | GlobeNewswire | +2.13% | +2.78% | |
| Exicure Presents Positive Topline Phase 2 Data for Burixafor in Multiple Myeloma at 2025 ASH Annual Meeting | Press release | GlobeNewswire | -3.16% | -20.50% | |
| Form 8-K EXICURE, INC. For: Nov 10 | SEC filing · Form 8-K | SEC EDGAR | — | +3.59% | |
| Form 8-K EXICURE, INC. For: Nov 06 | SEC filing · Form 8-K | SEC EDGAR | — | -2.10% | |
| Exicure, Inc. Reports Third Quarter 2025 Financial Results | Press release | GlobeNewswire | +0.00% | -3.25% | |
| Form 10-Q EXICURE, INC. For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | -3.25% | |
| Form 8-K EXICURE, INC. For: Nov 07 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -3.25% | |
| New Burixafor Clinical Data to be Presented as an Oral Presentation at the 2025 ASH Annual Meeting | Press release | GlobeNewswire | — | -8.48% | |
| Halper Sadeh LLC Encourages Exicure, Inc. Shareholders to Contact the Firm to Discuss Their Rights | Press release | Business Wire | +0.00% | +0.64% | |
| Exicure Highlights Recent Achievements and Near-term Strategic Priorities | Press release | GlobeNewswire | +0.00% | -1.61% | |
| Form DEF 14A EXICURE, INC. For: Sep 23 | SEC filing · Form DEF | SEC EDGAR | — | +19.38% | |
| Form 8-K EXICURE, INC. For: Sep 08 | SEC filing · Form 8-K | SEC EDGAR | -2.01% | -6.28% | |
| Exicure, Inc. Reports Second Quarter 2025 Financial Results | Press release | Business Wire | +0.07% | +6.01% | |
| Form 10-Q EXICURE, INC. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.07% | +6.01% | |
| Form 8-K EXICURE, INC. For: Aug 08 | SEC filing · Form 8-K | SEC EDGAR | +0.07% | +6.01% | |
| Exicure, Inc. (Nasdaq: XCUR) Regains Compliance with Nasdaq Filing Requirements | Press release | Business Wire | +0.47% | +3.21% | |
| Form 8-K EXICURE, INC. For: Aug 04 | SEC filing · Form 8-K | SEC EDGAR | +0.47% | +3.21% | |
| Exicure Completes the Last Patient, Last Visit in Phase 2 Study of GPC-100 for Stem Cell Mobilization in Multiple Myeloma Patients Undergoing Autologous Transplant | Press release | Business Wire | +0.00% | +3.97% | |
| Form EFFECT EXICURE, INC. | SEC filing · Form EFFECT | SEC EDGAR | — | +8.13% | |
| Form S-1 EXICURE, INC. | SEC filing · Form S-1 | SEC EDGAR | -0.41% | -3.43% | |
| Exicure, Inc. Reports First Quarter 2025 Financial Results | Press release | Business Wire | +4.20% | +9.49% | |
| Form 10-Q EXICURE, INC. For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +4.20% | +9.49% | |
| Form 8-K EXICURE, INC. For: Jun 27 | SEC filing · Form 8-K | SEC EDGAR | +4.20% | +9.49% | |
| Form 8-K EXICURE, INC. For: Jun 06 | SEC filing · Form 8-K | SEC EDGAR | — | -9.67% | |
| Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-Q | Press release | Business Wire | — | +2.21% | |
| Form 8-K EXICURE, INC. For: May 21 | SEC filing · Form 8-K | SEC EDGAR | — | +2.21% | |
| Form NT 10-Q EXICURE, INC. For: May 15 | SEC filing · Form NT | SEC EDGAR | — | -0.69% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the XCUR section they belong to.
Where else XCUR is measured.
XCUR earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| T2 Biosystems, Inc. (TTOO) | 174 | -0.92% | 40% |
| EARTH SCIENCE TECH INC (ETST) | 173 | 0.00% | 33% |
| Aytu BioPharma, Inc. (AYTU) | 172 | -0.14% | 40% |
| Alpine Immune Sciences, Inc. (ALPN) | 171 | +0.05% | 54% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Exicure, Inc.'s median reaction calculated?
Every labeled XCUR news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 173 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 49% of XCUR's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does XCUR's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.